Viewing Study NCT05361057


Ignite Creation Date: 2025-12-24 @ 6:49 PM
Ignite Modification Date: 2025-12-29 @ 1:38 AM
Study NCT ID: NCT05361057
Status: TERMINATED
Last Update Posted: 2025-12-05
First Post: 2022-03-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy of Venetoclax Based Regimen in Prevention Relapse of Consecutive MRD Positive AML Patients
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia View
None Measurable Disease View
Keywords: